Skip to content
Institutional Investor pre-seed seed Series A Series B growth Est. 2016

Digitalis Ventures

Investing in breakthrough science and technology to improve human and animal health

📍 New York City, United States

About This Fund

Investing in breakthrough science and technology to improve human and animal health. The company invests in biotechnology and technology-enabled solutions to address unmet needs in health. They provide venture capital to early-stage companies across life sciences, health technologies, services, and animal health. Their expertise and network of entrepreneurs, technical experts, research institutions, and financial partners allow them to forge deep relationships and create lasting solutions. The company also publishes insights on human and animal health, science, and technology. They are part of a group that includes applied research and a non-profit developing public-interest technologies for better health.

Investment Focus

Sectors
life sciences biotech healthtech animal health pet therapeutics veterinary tech
Stages
pre-seed seed Series A Series B growth
Check Size $250K-$50M+
Geography
USA Europe

What They Look For

US primary (Europe secondary), founders with deep domain expertise (MD, PhD, DVM preferred), breakthrough science/technology addressing unmet health needs, mission-driven multidisciplinary teams

Preparing to pitch Digitalis Ventures?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.

Analyze My Deck →